Concepts (242)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Thyroid Neoplasms | 2 | 2017 | 422 | 0.91 | Why? |
| Adrenomedullin | 2 | 2021 | 217 | 0.90 | Why? |
| Exosomes | 2 | 2018 | 567 | 0.90 | Why? |
| Protein Precursors | 2 | 2021 | 425 | 0.82 | Why? |
| Cellular Microenvironment | 1 | 2018 | 55 | 0.75 | Why? |
| Thyroid Gland | 3 | 2017 | 516 | 0.71 | Why? |
| Weightlessness | 1 | 2017 | 12 | 0.70 | Why? |
| Bacteremia | 2 | 2018 | 1372 | 0.69 | Why? |
| Radiation, Ionizing | 1 | 2017 | 39 | 0.68 | Why? |
| Synovial Fluid | 1 | 2017 | 64 | 0.66 | Why? |
| Blood Culture | 1 | 2018 | 308 | 0.62 | Why? |
| Hematologic Tests | 1 | 2019 | 521 | 0.57 | Why? |
| Osteoarthritis | 1 | 2017 | 205 | 0.56 | Why? |
| Sphingomyelin Phosphodiesterase | 4 | 2018 | 87 | 0.54 | Why? |
| Pregnancy-Associated Plasma Protein-A | 1 | 2013 | 8 | 0.54 | Why? |
| Blood Cell Count | 1 | 2019 | 1101 | 0.53 | Why? |
| Immune Tolerance | 1 | 2018 | 608 | 0.51 | Why? |
| Adipose Tissue | 1 | 2018 | 612 | 0.50 | Why? |
| Infant, Small for Gestational Age | 1 | 2013 | 151 | 0.49 | Why? |
| Peptide Fragments | 2 | 2021 | 2075 | 0.49 | Why? |
| Fetal Growth Retardation | 1 | 2013 | 217 | 0.43 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2021 | 13720 | 0.42 | Why? |
| Metabolic Syndrome | 1 | 2017 | 810 | 0.38 | Why? |
| Macrophages | 2 | 2018 | 2784 | 0.38 | Why? |
| Frail Elderly | 4 | 2019 | 1427 | 0.36 | Why? |
| Hypotension, Orthostatic | 2 | 2018 | 55 | 0.35 | Why? |
| Geriatric Assessment | 5 | 2019 | 1372 | 0.33 | Why? |
| Monocytes | 1 | 2019 | 2978 | 0.33 | Why? |
| Oxidative Stress | 2 | 2018 | 2050 | 0.32 | Why? |
| Nasopharynx | 2 | 2021 | 10224 | 0.28 | Why? |
| Heart Failure | 4 | 2019 | 6638 | 0.27 | Why? |
| Biomarkers | 8 | 2021 | 23361 | 0.26 | Why? |
| C-Reactive Protein | 2 | 2018 | 7972 | 0.24 | Why? |
| Limit of Detection | 2 | 2021 | 2698 | 0.24 | Why? |
| Reactive Oxygen Species | 2 | 2018 | 1136 | 0.22 | Why? |
| Workflow | 2 | 2021 | 2373 | 0.22 | Why? |
| Calcitriol | 2 | 2017 | 84 | 0.21 | Why? |
| Interleukin-2 Receptor alpha Subunit | 1 | 2021 | 234 | 0.20 | Why? |
| Daunorubicin | 1 | 2018 | 33 | 0.19 | Why? |
| Erythrocyte Count | 1 | 2019 | 137 | 0.19 | Why? |
| Membrane Microdomains | 1 | 2018 | 51 | 0.18 | Why? |
| Parkinson Disease, Secondary | 1 | 2017 | 15 | 0.18 | Why? |
| B-Cell Activating Factor | 1 | 2018 | 36 | 0.18 | Why? |
| Myelitis, Transverse | 1 | 2021 | 218 | 0.17 | Why? |
| Geriatricians | 1 | 2018 | 71 | 0.17 | Why? |
| Cytokines | 5 | 2021 | 15010 | 0.17 | Why? |
| Anti-Bacterial Agents | 2 | 2021 | 10083 | 0.17 | Why? |
| Chronic Disease | 5 | 2019 | 5139 | 0.17 | Why? |
| Galectin 3 | 1 | 2017 | 76 | 0.17 | Why? |
| Space Flight | 1 | 2017 | 37 | 0.17 | Why? |
| Hand Strength | 1 | 2018 | 202 | 0.16 | Why? |
| Apoptosis | 2 | 2017 | 2335 | 0.16 | Why? |
| RNA, Viral | 3 | 2021 | 32276 | 0.16 | Why? |
| tau Proteins | 1 | 2017 | 162 | 0.16 | Why? |
| Cholesterol | 2 | 2018 | 660 | 0.16 | Why? |
| Frailty | 2 | 2019 | 1432 | 0.15 | Why? |
| Cell Nucleus | 1 | 2018 | 399 | 0.15 | Why? |
| Antihypertensive Agents | 2 | 2018 | 1962 | 0.15 | Why? |
| Quality Control | 1 | 2019 | 628 | 0.15 | Why? |
| Amyloid beta-Peptides | 1 | 2017 | 185 | 0.15 | Why? |
| Hippocampus | 1 | 2017 | 237 | 0.15 | Why? |
| Running | 1 | 2017 | 153 | 0.15 | Why? |
| Immunoglobulin M | 3 | 2021 | 9091 | 0.15 | Why? |
| Syncope | 1 | 2018 | 238 | 0.14 | Why? |
| Drug Resistance, Neoplasm | 1 | 2018 | 447 | 0.14 | Why? |
| Neuroendocrine Tumors | 1 | 2018 | 241 | 0.14 | Why? |
| Muscle, Skeletal | 2 | 2018 | 915 | 0.13 | Why? |
| Antibodies, Viral | 5 | 2021 | 51949 | 0.13 | Why? |
| Humans | 42 | 2021 | 930598 | 0.13 | Why? |
| Nutrition Assessment | 1 | 2018 | 527 | 0.13 | Why? |
| Accidental Falls | 1 | 2018 | 448 | 0.13 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2018 | 398 | 0.13 | Why? |
| Renal Insufficiency | 1 | 2020 | 810 | 0.13 | Why? |
| Ozone | 1 | 2021 | 757 | 0.12 | Why? |
| Standard of Care | 1 | 2020 | 1297 | 0.12 | Why? |
| Prospective Studies | 9 | 2021 | 43301 | 0.12 | Why? |
| Sarcopenia | 1 | 2018 | 422 | 0.12 | Why? |
| Aged | 21 | 2021 | 215776 | 0.12 | Why? |
| Lipid Metabolism | 1 | 2017 | 572 | 0.12 | Why? |
| Cardiovascular Diseases | 1 | 2017 | 11497 | 0.12 | Why? |
| Cardiac Rehabilitation | 1 | 2018 | 525 | 0.12 | Why? |
| Stomach Neoplasms | 1 | 2017 | 477 | 0.12 | Why? |
| Weight Loss | 1 | 2017 | 826 | 0.11 | Why? |
| Aging | 2 | 2018 | 3581 | 0.11 | Why? |
| Serum Albumin, Human | 1 | 2013 | 265 | 0.11 | Why? |
| Area Under Curve | 1 | 2018 | 2564 | 0.11 | Why? |
| Chemokines | 1 | 2017 | 1095 | 0.11 | Why? |
| Pregnancy | 1 | 2013 | 23879 | 0.11 | Why? |
| Nutritional Status | 2 | 2019 | 1403 | 0.11 | Why? |
| Female | 24 | 2021 | 380317 | 0.11 | Why? |
| Male | 26 | 2021 | 367725 | 0.10 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2018 | 1115 | 0.10 | Why? |
| Multiple Organ Failure | 1 | 2021 | 1724 | 0.10 | Why? |
| Extracellular Vesicles | 1 | 2017 | 607 | 0.10 | Why? |
| Middle Aged | 17 | 2021 | 270681 | 0.10 | Why? |
| Serum Albumin | 1 | 2013 | 571 | 0.10 | Why? |
| Exercise Therapy | 1 | 2018 | 976 | 0.10 | Why? |
| Patient-Centered Care | 1 | 2018 | 860 | 0.10 | Why? |
| Blood Pressure | 2 | 2018 | 2198 | 0.10 | Why? |
| Troponin I | 1 | 2017 | 1298 | 0.09 | Why? |
| Italy | 8 | 2021 | 38444 | 0.09 | Why? |
| Carrier State | 1 | 2021 | 2100 | 0.09 | Why? |
| Longitudinal Studies | 2 | 2021 | 9893 | 0.09 | Why? |
| Predictive Value of Tests | 3 | 2019 | 9537 | 0.09 | Why? |
| Immunoglobulin G | 3 | 2021 | 21571 | 0.09 | Why? |
| Shock, Septic | 1 | 2018 | 1313 | 0.09 | Why? |
| Sphingomyelins | 2 | 2018 | 54 | 0.09 | Why? |
| Biomarkers, Tumor | 1 | 2018 | 1314 | 0.09 | Why? |
| Aged, 80 and over | 14 | 2021 | 88759 | 0.09 | Why? |
| Carcinoma, Hepatocellular | 1 | 2018 | 1222 | 0.09 | Why? |
| Malnutrition | 1 | 2018 | 932 | 0.09 | Why? |
| Antioxidants | 1 | 2018 | 1593 | 0.09 | Why? |
| Hematologic Neoplasms | 1 | 2021 | 2105 | 0.09 | Why? |
| Guillain-Barre Syndrome | 1 | 2020 | 1495 | 0.09 | Why? |
| Ultraviolet Rays | 1 | 2017 | 1272 | 0.08 | Why? |
| Leukocytes, Mononuclear | 1 | 2017 | 2115 | 0.08 | Why? |
| Alzheimer Disease | 1 | 2017 | 1020 | 0.08 | Why? |
| Inflammation | 2 | 2021 | 13255 | 0.08 | Why? |
| Liver Neoplasms | 1 | 2018 | 1666 | 0.08 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.08 | Why? |
| Hypertension | 2 | 2018 | 8895 | 0.08 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.08 | Why? |
| Follow-Up Studies | 2 | 2021 | 17020 | 0.08 | Why? |
| Retrospective Studies | 7 | 2021 | 105322 | 0.07 | Why? |
| Dementia | 1 | 2018 | 1861 | 0.07 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.07 | Why? |
| Atrial Fibrillation | 1 | 2018 | 2320 | 0.07 | Why? |
| Immunologic Factors | 1 | 2020 | 4206 | 0.07 | Why? |
| Risk Factors | 8 | 2021 | 71621 | 0.06 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.06 | Why? |
| Immunity, Innate | 1 | 2021 | 6570 | 0.06 | Why? |
| Multivariate Analysis | 3 | 2018 | 5440 | 0.06 | Why? |
| Macrophage Colony-Stimulating Factor | 1 | 2021 | 30 | 0.06 | Why? |
| Sepsis | 1 | 2018 | 3517 | 0.06 | Why? |
| Independent Living | 2 | 2018 | 842 | 0.05 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.05 | Why? |
| Hepatocyte Growth Factor | 1 | 2021 | 71 | 0.05 | Why? |
| Pneumonia | 1 | 2021 | 5652 | 0.05 | Why? |
| Animals | 4 | 2017 | 78931 | 0.05 | Why? |
| Kidney Transplantation | 1 | 2020 | 5397 | 0.05 | Why? |
| Cohort Studies | 3 | 2018 | 36005 | 0.05 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.05 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.05 | Why? |
| Adult | 10 | 2021 | 244371 | 0.05 | Why? |
| Prognosis | 2 | 2021 | 32490 | 0.05 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.05 | Why? |
| Respiratory Insufficiency | 1 | 2021 | 7301 | 0.05 | Why? |
| Lamin Type B | 1 | 2018 | 5 | 0.05 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.05 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.05 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 3832 | 0.05 | Why? |
| Cell Line, Tumor | 2 | 2018 | 3608 | 0.05 | Why? |
| Pulmonary Embolism | 1 | 2018 | 4775 | 0.05 | Why? |
| MPTP Poisoning | 1 | 2017 | 2 | 0.05 | Why? |
| Critical Illness | 2 | 2021 | 17281 | 0.05 | Why? |
| Receptors, Thyrotropin | 1 | 2017 | 8 | 0.05 | Why? |
| Enzyme Induction | 1 | 2017 | 89 | 0.04 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.04 | Why? |
| Nitrates | 1 | 2018 | 98 | 0.04 | Why? |
| Exercise | 1 | 2018 | 6771 | 0.04 | Why? |
| Autoantigens | 1 | 2020 | 388 | 0.04 | Why? |
| Nitric Oxide Synthase Type II | 1 | 2017 | 119 | 0.04 | Why? |
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2017 | 66 | 0.04 | Why? |
| Respiratory Tract Infections | 1 | 2018 | 6817 | 0.04 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.04 | Why? |
| Receptors, Calcitriol | 1 | 2017 | 102 | 0.04 | Why? |
| Physical Endurance | 1 | 2017 | 107 | 0.04 | Why? |
| STAT3 Transcription Factor | 1 | 2018 | 268 | 0.04 | Why? |
| Prevalence | 4 | 2021 | 25773 | 0.04 | Why? |
| Diuretics | 1 | 2018 | 326 | 0.04 | Why? |
| Thyrotropin | 1 | 2017 | 262 | 0.04 | Why? |
| Electric Impedance | 1 | 2018 | 283 | 0.04 | Why? |
| Statistics as Topic | 1 | 2017 | 370 | 0.03 | Why? |
| HLA Antigens | 1 | 2020 | 830 | 0.03 | Why? |
| Body Composition | 1 | 2018 | 414 | 0.03 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2017 | 604 | 0.03 | Why? |
| Kinetics | 1 | 2021 | 3238 | 0.03 | Why? |
| Oxygen Consumption | 1 | 2017 | 711 | 0.03 | Why? |
| Treatment Outcome | 4 | 2021 | 51732 | 0.03 | Why? |
| Down-Regulation | 1 | 2018 | 1416 | 0.03 | Why? |
| Lung | 1 | 2021 | 31049 | 0.03 | Why? |
| Infant, Newborn | 1 | 2013 | 23105 | 0.03 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.03 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.03 | Why? |
| Creatinine | 1 | 2017 | 1443 | 0.03 | Why? |
| Seroconversion | 1 | 2021 | 2515 | 0.03 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 1573 | 0.03 | Why? |
| Critical Pathways | 1 | 2021 | 1587 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2018 | 1887 | 0.03 | Why? |
| Polymorphism, Genetic | 1 | 2017 | 1074 | 0.03 | Why? |
| Up-Regulation | 1 | 2018 | 2249 | 0.02 | Why? |
| Diagnostic Tests, Routine | 1 | 2021 | 2643 | 0.02 | Why? |
| Autoantibodies | 1 | 2020 | 2094 | 0.02 | Why? |
| Hospitals | 2 | 2020 | 11793 | 0.02 | Why? |
| Genotype | 1 | 2020 | 4697 | 0.02 | Why? |
| Computed Tomography Angiography | 1 | 2018 | 2153 | 0.02 | Why? |
| Mice | 2 | 2017 | 21357 | 0.02 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.02 | Why? |
| Heart | 1 | 2017 | 1791 | 0.02 | Why? |
| Phenotype | 1 | 2019 | 4037 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Age Factors | 2 | 2019 | 21039 | 0.02 | Why? |
| Hydrocortisone | 1 | 2017 | 1790 | 0.02 | Why? |
| Hospital Mortality | 2 | 2021 | 22087 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
| Disabled Persons | 1 | 2017 | 1152 | 0.02 | Why? |
| Inflammation Mediators | 1 | 2017 | 2654 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.02 | Why? |
| Risk | 1 | 2017 | 5288 | 0.02 | Why? |
| Glucocorticoids | 1 | 2020 | 4431 | 0.02 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.02 | Why? |
| Algorithms | 1 | 2021 | 7346 | 0.02 | Why? |
| Nursing Homes | 1 | 2021 | 4155 | 0.02 | Why? |
| Length of Stay | 1 | 2021 | 11042 | 0.02 | Why? |
| Venous Thrombosis | 1 | 2018 | 2739 | 0.02 | Why? |
| Interleukin-6 | 1 | 2021 | 7522 | 0.02 | Why? |
| Cell Line | 1 | 2017 | 12040 | 0.01 | Why? |
| Mortality | 1 | 2018 | 7132 | 0.01 | Why? |
| Socioeconomic Factors | 1 | 2019 | 8495 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.01 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 5277 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Cross-Sectional Studies | 2 | 2018 | 53120 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.01 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.01 | Why? |
| Glycated Hemoglobin A | 1 | 1985 | 1316 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2021 | 12447 | 0.01 | Why? |
| Hospitalization | 2 | 2018 | 54280 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2021 | 14232 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.01 | Why? |
| Comorbidity | 1 | 2019 | 34796 | 0.01 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.01 | Why? |
| Opioid-Related Disorders | 1 | 1985 | 1185 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
| Mental Health | 1 | 2019 | 15770 | 0.01 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.01 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.01 | Why? |
| Blood Glucose | 1 | 1985 | 3642 | 0.00 | Why? |
Curcio's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(242)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(101)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_